PATHOPHYSIOLOGY AND CLINICAL FEATURES OF RESTLESS LEGS SYNDROME
Journal Title: World Journal of Pharmaceutical and Medical Research - Year 2019, Vol 5, Issue 2
Abstract
Restless legs syndrome is a chronic sensorimotor disorder that involves sensory discomfort in the legs or other parts of the body, arising or increasing at rest, in the evening / night, and causing the need for movement. Despite the high prevalence and a significant impact on the quality of life, general practitioners, first-level specialists and the neurologists themselves are not sufficiently aware of this disease, and therefore it often remains a misdiagnosed state.
Authors and Affiliations
M. M. Raimova
Keywords
Related Articles
- EP ID EP675272
- DOI -
- Views 172
- Downloads 0
ROLE OF FOXO PROTEIN IN OSTEOARTHRITIS AND ITS TREATMENT: GAME CHANGER IN THE FIELD OF RHEMATOLOGY
Osteoarthritis is the most common age related disease affecting older individual. Most commonly it involves weight bearing joints in human. Reduced expression of FOXO proteins has been found to be associated with develop...
ASTHMA AND OBESITY AMONG CHILDREN IN BASRA
Background: Asthma and obesity are two of the most common conditions of childhood and adolescence. The prevalence of asthma has increased worldwide during the last several decades, An increasing trend in body mass index...
VARIOUS METHODS OF AGE ESTIMATION: A REVIEW
Age estimation provides a valuable tool in forensic cases. Various methods like morphological age, secondary sexual characters, skeletal age indicators and dental age indicators are used in the forensic investigation as...
YAVA (BARLEY-HORDEUM VULGARE) - A FOOD AND PANACEA
A well planned diet and proper dietary practices plays a major role in promotion of health. Yava is in practice since ancient period due to its rich nutritional entities and various therapeutic benefits. This paper revie...
CARDIOVASCULAR OUTCOME TRIALS IN TYPE 2 DIABETES: RELIABLE OR BIASED!
Several recent multinational clinical trials have suggested improvement in cardiovascular outcomes with antihyperglycemic agents in subjects with type 2 diabetes.[1-4] First and foremost, the designs implemented in these...